HomeCompareTRATF vs PFE

TRATF vs PFE: Dividend Comparison 2026

TRATF yields 3.09% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRATF wins by $2.73M in total portfolio value
10 years
TRATF
TRATF
● Live price
3.09%
Share price
$35.00
Annual div
$1.08
5Y div CAGR
69.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.77M
Annual income
$2,096,038.85
Full TRATF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — TRATF vs PFE

📍 TRATF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRATFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRATF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRATF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRATF
Annual income on $10K today (after 15% tax)
$262.29/yr
After 10yr DRIP, annual income (after tax)
$1,781,633.02/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, TRATF beats the other by $1,759,313.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRATF + PFE for your $10,000?

TRATF: 50%PFE: 50%
100% PFE50/50100% TRATF
Portfolio after 10yr
$1.41M
Annual income
$1,061,148.79/yr
Blended yield
75.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TRATF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
1.1
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRATF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRATFPFE
Forward yield3.09%6.13%
Annual dividend / share$1.08$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR69.6%13.2%
Portfolio after 10y$2.77M$49.6K
Annual income after 10y$2,096,038.85$26,258.71
Total dividends collected$2.69M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: TRATF vs PFE ($10,000, DRIP)

YearTRATF PortfolioTRATF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,223$523.34$9,153$693.39+$2.1KTRATF
2$12,940$930.99$8,593$849.25+$4.3KTRATF
3$15,547$1,701.37$8,336$1,066.78+$7.2KTRATF
4$19,876$3,240.10$8,437$1,384.80+$11.4KTRATF
5$27,832$6,565.51$9,013$1,875.40+$18.8KTRATF
6$44,353$14,572.74$10,306$2,680.72+$34.0KTRATF
7$84,268$36,809.52$12,820$4,101.38+$71.4KTRATF
8$201,017$110,850.23$17,673$6,826.70+$183.3KTRATF
9$634,219$419,131.14$27,543$12,591.86+$606.7KTRATF
10$2,774,653$2,096,038.85$49,560$26,258.71+$2.73MTRATF

TRATF vs PFE: Complete Analysis 2026

TRATFStock

Traton SE manufactures commercial vehicles worldwide. It operates in Industrial Business and Financial Services segments. The company offers light and heavy-duty commercial vehicles, such as trucks and bus chassis; vans; construction vehicles; city buses; and intercity and travel coaches, as well as spare parts and services. It also provides a cloud-based platform for freight transportation under the RIO brand name. The company offers its products and services under the MAN, Scania, Navistar, and Volkswagen Caminhões e Ônibus brands. In addition, it provides a range of financial solutions, including dealer and customer finance, leasing, and insurance products. The company was founded in 2015 and is based in Munich, Germany. Traton SE is a subsidiary of Volkswagen Finance Luxemburg S.A.

Full TRATF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TRATF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRATF vs SCHDTRATF vs JEPITRATF vs OTRATF vs KOTRATF vs MAINTRATF vs JNJTRATF vs MRKTRATF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.